Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Estrogen and colorectal cancer incidence and mortality.

Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell FA, Mahinbakht A, Simon MS.

Cancer. 2015 Sep 15;121(18):3261-71. doi: 10.1002/cncr.29464. Epub 2015 Jun 2.

2.

Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies.

Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, Chen C, Chlebowski RT, Hubbell FA, Kooperberg C, Manson JE, O'Sullivan MJ, Rohan T, Stefanick ML, Wactawski-Wende J, Wakelee H, Simon MS.

J Thorac Oncol. 2015 Jul;10(7):1004-13. doi: 10.1097/JTO.0000000000000558.

3.

Mammography interval and breast cancer mortality in women over the age of 75.

Simon MS, Wassertheil-Smoller S, Thomson CA, Ray RM, Hubbell FA, Lessin L, Lane DS, Kuller LH.

Breast Cancer Res Treat. 2014 Nov;148(1):187-95. doi: 10.1007/s10549-014-3114-4. Epub 2014 Sep 25.

4.

Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.

Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):365-73. doi: 10.1158/1055-9965.EPI-12-1225. Epub 2012 Dec 28.

5.

Estrogen plus progestin and colorectal cancer incidence and mortality.

Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell FA, Prentice RL.

J Clin Oncol. 2012 Nov 10;30(32):3983-90. doi: 10.1200/JCO.2012.42.7732. Epub 2012 Sep 24. Erratum in: J Clin Oncol. 2013 Jun 1;31(16):2063.

6.

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell FA, Lane D, Martin L, Ockene J, Rohan T, Schenken R, Wactawski-Wende J.

Lancet Oncol. 2012 May;13(5):476-86. doi: 10.1016/S1470-2045(12)70075-X. Epub 2012 Mar 7.

7.

Evaluating breast cancer risk projections for Hispanic women.

Banegas MP, Gail MH, LaCroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell FA, Yasmeen S, Katki HA.

Breast Cancer Res Treat. 2012 Feb;132(1):347-53. doi: 10.1007/s10549-011-1900-9. Epub 2011 Dec 7.

8.

Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative.

Simon MS, Thomson CA, Pettijohn E, Kato I, Rodabough RJ, Lane D, Hubbell FA, O'Sullivan MJ, Adams-Campbell L, Mouton CP, Abrams J, Chlebowski RT.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1368-78. doi: 10.1158/1055-9965.EPI-11-0027. Epub 2011 May 20.

9.

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.

Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS, Lee JS.

J Natl Cancer Inst. 2011 Apr 6;103(7):562-70. doi: 10.1093/jnci/djr031. Epub 2011 Feb 17.

10.

Social Support for Chamorro Breast Cancer Survivors on Guam.

Perez LA, Natividad L, Chung W, Haddock RL, Wenzel L, Hubbell FA.

Calif J Health Promot. 2010 Dec;8(Spec iss):63-72.

11.

25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.

Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, Rohan T, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA.

Maturitas. 2011 Jan;68(1):73-8. doi: 10.1016/j.maturitas.2010.10.006. Epub 2010 Nov 18.

12.

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.

Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski-Wende J, Kotchen JM, Ockene JK, O'Sullivan MJ, Hubbell FA, Chien JW, Chen C, Stefanick ML.

J Natl Cancer Inst. 2010 Sep 22;102(18):1413-21. doi: 10.1093/jnci/djq285. Epub 2010 Aug 13.

13.

Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.

Chlebowski RT, Anderson G, Manson JE, Pettinger M, Yasmeen S, Lane D, Langer RD, Hubbell FA, McTiernan A, Hendrix S, Schenken R, Stefanick ML.

J Clin Oncol. 2010 Jun 1;28(16):2690-7. doi: 10.1200/JCO.2009.24.8799. Epub 2010 May 3.

14.

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.

Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Johnson KC, O'Sullivan MJ, Ockene JK, Chen C, Hubbell FA; Women's Health Initiative Investigators.

Lancet. 2009 Oct 10;374(9697):1243-51. doi: 10.1016/S0140-6736(09)61526-9. Epub 2009 Sep 18.

15.

Vasomotor symptoms, adoption of a low-fat dietary pattern, and risk of invasive breast cancer: a secondary analysis of the Women's Health Initiative randomized controlled dietary modification trial.

Caan BJ, Aragaki A, Thomson CA, Stefanick ML, Chlebowski R, Hubbell FA, Tinker L, Vitolins M, Rajkovic A, Bueche M, Ockene J.

J Clin Oncol. 2009 Sep 20;27(27):4500-7. doi: 10.1200/JCO.2008.20.0493. Epub 2009 Aug 17.

16.

Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study.

Prentice RL, Pettinger M, Beresford SA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1531-7. doi: 10.1158/1055-9965.EPI-08-1209.

17.

Calcium plus vitamin D supplementation and the risk of breast cancer.

Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2008 Nov 19;100(22):1581-91. doi: 10.1093/jnci/djn360. Epub 2008 Nov 11.

18.

Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women.

De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A, Arias C, Manetta A.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2163-8. doi: 10.1158/1055-9965.EPI-07-2935.

19.

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL.

Am J Epidemiol. 2008 Jun 15;167(12):1407-15. doi: 10.1093/aje/kwn090. Epub 2008 Apr 29.

20.

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, Jo O'Sullivan M, Rossouw JE, Anderson GL.

Am J Epidemiol. 2008 May 15;167(10):1207-16. doi: 10.1093/aje/kwn044. Epub 2008 Mar 27.

Supplemental Content

Loading ...
Support Center